Garvan Institute of Medical Research

Garvan Institute of Medical Research Garvan Institute of Medical Research is a world leader, pioneering study into some of the most widespread diseases of today.

It aims to understand the genetic, molecular and cellular processes of health and disease as a basis for developing future cures.

Our researchers are on a mission to make everyday moments easier for people living with arthritis. Your support is urgen...
24/03/2026

Our researchers are on a mission to make everyday moments easier for people living with arthritis. Your support is urgently needed to keep this research moving.

Arthritis is a daily battle of pain, stiffness and swelling. For some, it’s a systemic condition where the immune system can damage vital organs like the heart and lungs. On top of this, it can take years of trial and error before an effective treatment is found.

Right now, Dr Etienne Masle-Farquhar and his team are using powerful new technologies to study immune cells within diseased tissue for faster, more precise arthritis treatments. This groundbreaking work could transform treatment options for the one in seven Australians living with arthritis.

There is still time to join us as we accelerate discoveries and transform this chronic condition into a manageable one. With your support today, we can keep vital arthritis research moving forward, and reduce the time people spend living with pain.

👉 Support our research: https://ow.ly/Fsgo50YxUVj

21/03/2026

For the 1 in 7 Australians living with arthritis, life is a daily battle with pain, stiffness and swelling.

Join us at our upcoming public seminar to hear how Dr Etienne Masle-Farquhar and his team are shaping a future where people with arthritis can live with less pain.

Register to attend in person or online: https://ow.ly/26zb50YwGn8

21/03/2026

We are getting excited for our upcoming seminar! Have you registered your place yet?

Join Dr Etienne Masle-Farquhar, in person or online, to discover how his team is shaping a future where people with arthritis can live with less pain.

Register here: https://ow.ly/wrX250Yv2Kk

20/03/2026

For more than 20 years, Kevin has lived with psoriatic arthritis. His chronic pain began in his toes and gradually travelled all the way up to his neck.

Kevin shares the reality of living with arthritic flare-ups and what a typical day with chronic pain looks like.

Help us find life-changing treatments for people like Kevin.

Support or learn more about our research today:
https://ow.ly/lXTr50YwGi5

The inaugural AllClear Research Symposium brought together over 120 patient advocates, clinicians, surgeons, nurses and ...
19/03/2026

The inaugural AllClear Research Symposium brought together over 120 patient advocates, clinicians, surgeons, nurses and researchers to tackle one of the most urgent challenges in breast cancer: disease relapse.

Led by A/Prof Christine Chaffer and Prof Peter Croucher and funded by National Breast Cancer Foundation, the symposium moved beyond discussion to deliver concrete outcomes: discovering the causes of relapse, predicting who will relapse and developing new relapse-targeting therapies, advancing AllClear’s adaptive clinical trial platform, and ensuring equitable trial access for every patient.

Together, we are working to turn the ‘all clear’ from a hope into a clinical reality. Thank you to all who attended for your engagement and collaborative spirit.

Read more about the mission: https://ow.ly/9JHW50Yw9t2

Immunotherapy has revolutionised the treatment of many blood cancers, harnessing the immune system so our bodies can fig...
18/03/2026

Immunotherapy has revolutionised the treatment of many blood cancers, harnessing the immune system so our bodies can fight back.

But for solid tumours, like pancreatic cancer, that breakthrough has remained frustratingly out of reach.

So, why does the immune system struggle to infiltrate these biological barriers?

🎧 In this brand new episode of our Medical Minds podcast, we speak to Associate Professor Maté Biro whose research into how cancer cells move is shedding light on one of cancer’s toughest challenges.

Listen to the episode here: https://ow.ly/eprt50YvBP9

We were thrilled to welcome more than 80 guests to Garvan last Friday for our annual International Women’s Day lunch, ce...
17/03/2026

We were thrilled to welcome more than 80 guests to Garvan last Friday for our annual International Women’s Day lunch, celebrating the women and community who drive scientific discovery.

Guests heard from an expert panel featuring Garvan’s Chief Translation Officer, Dr Rachel Galimidi, alongside Kayleigh Flynn and Dr Mugdha Bhati from the Biologics Platform.

Executive Director and Chief Executive Officer, Professor Benjamin Kile, also spoke at the event, sharing insights into Garvan’s research priorities and strategic direction.

It was an inspiring afternoon of scientific discussion, connection and collaboration.

We are deeply grateful to our incredible Garvan community – whose curiosity, generosity and commitment help to make groundbreaking research possible.

We look forward to celebrating International Women’s Day together again next year.

16/03/2026

For someone living with chronic pain, conveying its impact to others can be as challenging as enduring the pain itself.

Dr Etienne Masle-Farquhar highlights how arthritis pain is often misunderstood and not fully captured by existing pain assessments.

Support this research or learn more about how our team at Garvan is working to develop faster, more effective treatments for arthritis – so people can spend less time in pain.

https://ow.ly/s5FK50YuyWY

This is the power of clinical trials.Julian was diagnosed with stage 4 cancer in 2019 and had limited success with stand...
13/03/2026

This is the power of clinical trials.

Julian was diagnosed with stage 4 cancer in 2019 and had limited success with standard cancer treatments.

With the help of the NSW Early Phase Clinical Trials Alliance (NECTA), coordinated by Garvan, he was able to access ground-breaking trials with treatments not otherwise available in Australia. He is currently enjoying a full and active life.

Now, thanks to Cancer Institute NSW, NECTA has received a funding boost to expand its services to more Australians.

Read more about NECTA and Julian’s story:
https://ow.ly/y37J50YtbNn

On , we are sharing Rosie’s story.After inheriting polycystic kidney disease (PKD) from her father, Rosie had always fa...
11/03/2026

On , we are sharing Rosie’s story.

After inheriting polycystic kidney disease (PKD) from her father, Rosie had always faced uncertainty about her family’s future. But attending a Garvan seminar gave her something she hadn’t had before: hope.

“They said that in the future they might be able to slow down my disease or turn off the gene,” Rosie says. “I have hope that my son has a life that is not limited by PKD, even if he has inherited my kidneys.”

Through Garvan’s Rare Disease Registry, our researchers are working to fast-track diagnosis and targeted therapies – changing lives for families like Rosie’s, now and for future generations.

Learn more about our Rare Disease Registry:
https://ow.ly/z0S150Yr361

One in seven Australians live with arthritis. The path to treatment is often a trial and error process that can take mon...
11/03/2026

One in seven Australians live with arthritis.

The path to treatment is often a trial and error process that can take months, or even years, all while irreversible damage is being done to their bodies.

Determined to transform a chronic condition into a manageable one, Garvan researchers are moving beyond the current one-size-fits-all approach and toward a smarter, more targeted way to treat arthritis.

Using advanced technologies and samples from inflamed tissue, this work puts us at the forefront of arthritis research.

Your support can help to accelerate this progress and reduce the time people spend living with pain.

To support or learn more about this research, visit: https://ow.ly/t6Th50YqWqc

We were delighted to welcome members of the Immunodeficiency Foundation New Zealand (IDFNZ) to Garvan.As key stakeholder...
10/03/2026

We were delighted to welcome members of the Immunodeficiency Foundation New Zealand (IDFNZ) to Garvan.

As key stakeholders for the Clinical Immunogenomics Research Consortium Australasia (CIRCA), they have played an important role in strengthening our connections in New Zealand and supporting collaboration between researchers and the patient community.

It was a pleasure to host our guests, provide an overview of our work, and mark the visit with a group photograph.

To learn more about CIRCA and our research at Garvan, visit:
https://ow.ly/zAag50YpYTY

Address

384 Victoria Street
Darlinghurst, NSW
2010

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Garvan Institute of Medical Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Garvan Institute of Medical Research:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category